abiraterone has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, AA; Lutsey, PL; Prizment, A; Rao, A; Rubin, N; Ryan, CJ; Shah, S; Tholkes, A | 1 |
1 other study(ies) available for abiraterone and Cardiovascular Stroke
| Article | Year |
|---|---|
Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients.
Topics: Adult; Androgen Antagonists; Androstenes; Benzamides; Humans; Male; Myocardial Infarction; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Stroke | 2021 |